Study unveils mechanisms driving pain in myotonic disorders
Preclinical results point to the potential of targeted treatment for pain associated with this broad group of rare, inherited neuromuscular conditions.
Preclinical results point to the potential of targeted treatment for pain associated with this broad group of rare, inherited neuromuscular conditions.
UF is leading a team developing a battery‑free, needle‑injectable neural stimulator that shows promise in rodent models.
Study testing a combination therapy involving CBD in animal models shows promise in the hunt for treatment strategies to lower the dose of opioids for chronic pain.
Dr. Tyler Nelson's diagnosis of periodic paralysis inspired a new focus in his work as a young neuroscientist at the MBI.
MBI researchers found that optimism, good sleep, social support and other healthy habits were associated with slower brain aging, even in people living with chronic pain.
In The Conversation's Curious Kids series, Dr. Yenisel Cruz-Almeida explains pain, how it travels, and why it's needed as a warning signal.
New nonopioid compound shows potential for mitigating pain in preclinical animal models, human cells.
Dr. Rajesh Khanna is targeting key proteins involved in pain pathways, with a goal of safely “turning down the volume” on pain.
MBI researchers Drs. Yenisel Cruz-Almeida and Kyle Allen will train postdoctoral fellows in effort to develop new non-opioid treatments for pain management.
With $10 million NIH grant, Drs. Kyle Allen and Yenisel Cruz-Almeida seek to explore pain pathways and create custom treatments.